학술논문

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
Document Type
Article
Source
In The Lancet Gastroenterology & Hepatology March 2018 3(3):162-171
Subject
Primary Research
Articles
Language
ISSN
2468-1253